Datroway gets FDA nod
Datroway's treatment for triple-negative breast cancer receives FDA approval, potentially expanding treatment options. This may impact related biotech stocks.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Datroway's treatment for triple-negative breast cancer receives FDA approval, potentially expanding treatment options. This may impact related biotech stocks.